A randomized controlled trial of an educational intervention to improve phosphate levels in hemodialysis patients

被引:66
作者
Ashurst, ID [1 ]
Dobbie, H [1 ]
机构
[1] Middlesex Hosp, Dept Nutr & Dietet, Ctr Nephrol, London W1W 7EY, England
关键词
D O I
10.1053/S1051-2276(03)00116-X
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Objective: To determine the effect of a dietetic educational intervention on phosphate and calcium levels of hemodialysis patients. Design: Parallel-group randomized controlled trial. Setting: Teaching hospital hemodialysis unit in London, England. Patients: Fifty-six stable adult hemodialysis patients with hyperphosphatemia. Intervention: An educational intervention and one-to-one teaching session given by a renal dietitian, attempting to improve patients' knowledge of phosphate management and their compliance with diet and medication. Outcome Measurement: Patients' serum phosphate, calcium, and calcium X phosphate products in the 3 months after the intervention, compared with those before the intervention. Results were also compared with a control group that had not undergone the intervention. Results: In the intervention group, serum phosphate was significantly reduced after the education session, as compared with the results previously. In the control group, there was no significant change in serum phosphate level. The improved results were sustained over a period of 3 months. Serum calcium increased in the intervention group, but this result was not significant. There was an improvement in the calcium-phosphate product in the intervention group, but again this was not significant. Conclusion: Dietetic educational intervention can favorably alter patients' serum phosphate levels, with potential impact on morbidity and mortality. (C) 2003 by the National Kidney Foundation, Inc.
引用
收藏
页码:267 / 274
页数:8
相关论文
共 23 条
[1]  
ANSELL D, 2002, UK RENAL REGISTRY RE
[2]   Non-compliance in patients receiving haemodialysis: An in-depth review [J].
Baines, LS ;
Jindal, RM .
NEPHRON, 2000, 85 (01) :1-7
[3]   Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease [J].
Blacher, J ;
Guerin, AP ;
Pannier, B ;
Marchais, SJ ;
London, GM .
HYPERTENSION, 2001, 38 (04) :938-942
[4]   Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study [J].
Block, GA ;
Hulbert-Shearon, TE ;
Levin, NW ;
Port, FK .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 31 (04) :607-617
[5]   Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients [J].
Chertow, GM ;
Burke, SK ;
Raggi, P .
KIDNEY INTERNATIONAL, 2002, 62 (01) :245-252
[6]   Calciphylaxis is usually non-ulcerating: Risk factors, outcome and therapy [J].
Fine, A ;
Zacharias, J .
KIDNEY INTERNATIONAL, 2002, 61 (06) :2210-2217
[7]  
Foley RN, 1998, J AM SOC NEPHROL, V9, P267
[8]  
Ganesh SK, 2001, J AM SOC NEPHROL, V12, P2131, DOI 10.1681/ASN.V12102131
[9]   Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis [J].
Goodman, WG ;
Goldin, J ;
Kuizon, BD ;
Yoon, C ;
Gales, B ;
Sider, D ;
Wang, Y ;
Chung, J ;
Emerick, A ;
Greaser, L ;
Elashoff, RM ;
Salusky, IB .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (20) :1478-1483
[10]   Arterial stiffening and vascular calcifications in end-stage renal disease [J].
Guérin, AP ;
London, GM ;
Marchais, SJ ;
Metivier, F .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2000, 15 (07) :1014-1021